Concepedia

Publication | Open Access

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer

330

Citations

26

References

2010

Year

Abstract

IPI-504 has clinical activity in patients with NSCLC, particularly among patients with ALK rearrangements.

References

YearCitations

Page 1